We then sought to explore the therapeutic benefit of targeting Mettl14 by hf Cas13x in an early‐phase therapeutic model on doxorubicin‐induced cardiotoxicity. Briefly, CRISPR‐cr3‐4/ hf Cas13x or ...

Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...

A dose of 3.0 MBq of [18 F] 3 or [18 F] 4 was intravenously injected into the tail vein, and a dynamic scan was acquiring using a PET scanner (MOLECUBES, beta-cube) for 60 min. In the blocking studies ...